This course is a comprehensive yet concise program for updating physicians on commonly encountered problems in the treatment of liver diseases.
San Diego Mission Bay Resort
1775 E Mission Bay Drive
San Diego, California 92109
Room Block is Now Closed
This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
After attending this live activity, participants should be able to:
- Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.
- Review vascular disorders and coagulation management principles for patients with chronic liver disease.
- Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).
- Evaluate drugs in development for PBC and PSC.
- Employ strategies for treating and managing ascites and hepatorenal syndrome.
- Describe advances in HCC therapy and management of acute-on-chronic liver disease.
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses and Nurse Practitioners
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.
For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.
The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
PAs may claim a maximum of 10 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
This course is supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards
Cultural & Linguistic Competency and Implicit Bias
This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.
Date and time
Sun, Mar 13, 2022 at 11:30 am